Kidney Disease: Improving Global Outcomes-an update

被引:21
|
作者
Kasiske, Bertram L. [1 ]
Wheeler, David C. [2 ]
机构
[1] Hennepin Cty Med Ctr, Div Nephrol, Minneapolis, MN 55415 USA
[2] UCL Med Sch, Ctr Nephrol, London, England
关键词
controversies conferences; guidelines; implementation; KDIGO; methodology; CLINICAL-PRACTICE GUIDELINES; POSITION STATEMENT; CLASSIFICATION; DEFINITION;
D O I
10.1093/ndt/gft441
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Kidney Disease: Improving Global Outcomes (KDIGO) was founded in 2003 to fulfill a need for international cooperation and consolidation in the development and implementation of clinical practice guidelines. KDIGO has experienced a rapid growth in the development of guidelines, producing three guidelines in its first 6 years and another six in the last 3 years. In addition, it has held 12 global conferences on important issues in kidney disease and its treatment. A major effort is under way to support the dissemination and implementation of KDIGO guidelines through various channels, including an Implementation Task Force with official representatives in 86 countries. KDIGO is now under its own management and remains committed to the development of evidence-based guidelines. Future challenges include finding adequate sources of funding and building stronger links with other organizations involved in guideline development and implementation.
引用
收藏
页码:763 / 769
页数:8
相关论文
共 50 条
  • [21] Outcome of acute kidney injury (AKI) in cirrhotic patients using modified KDIGO (kidney disease improving global outcomes) criteria
    Mathew, Jose
    Devadas, Krishnadas
    Sandesh, K.
    Neeraj, V
    Yadav, Manoj
    Srijaya, S.
    Shanid, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 407 - 407
  • [22] Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement
    Covic, Adrian
    Abramowicz, Daniel
    Bruchfeld, Annette
    Leroux-Roels, Geert
    Samuel, Didier
    van Biesen, Wim
    Zoccali, Carmine
    Zoulim, Fabien
    Vanholder, Raymond
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (03) : 719 - 727
  • [23] Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    Locatelli, Francesco
    Nissenson, Allen R.
    Barrett, Brendan J.
    Walker, Rowan G.
    Wheeler, David C.
    Eckardt, Kai U.
    Lameire, Norbert H.
    Eknoyan, Garabed
    KIDNEY INTERNATIONAL, 2008, 74 (10) : 1237 - 1240
  • [24] Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement
    Heemann, Uwe
    Abramowicz, Daniel
    Spasovski, Goce
    Vanholder, Raymond
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (07) : 2099 - 2106
  • [25] Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement
    Goldsmith, David J. A.
    Covic, Adrian
    Fouque, Denis
    Locatelli, Francesco
    Olgaard, Klaus
    Rodriguez, Mariano
    Spasovski, Goce
    Urena, Pablo
    Zoccali, Carmine
    London, Gerard Michel
    Vanholder, Raymond
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (12) : 3823 - 3831
  • [26] Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
    Jha, Vivekanand
    Arici, Mustafa
    Collins, Allan J.
    Garcia-Garcia, Guillermo
    Hemmelgarn, Brenda R.
    Jafar, Tazeen H.
    Pecoits-Filho, Roberto
    Sola, Laura
    Swanepoel, Charles R.
    Tchokhonelidze, Irma
    Wang, Angela Yee Moon
    Kasiske, Bertram L.
    Wheeler, David C.
    Spasovski, Goce
    KIDNEY INTERNATIONAL, 2016, 90 (06) : 1164 - 1174
  • [27] The French clinician's guide to the Kidney disease: Improving global outcomes (KDIGO) for chronic kidney disease-mineral and bone disorders (CKD-MBD)
    Jean, G.
    Chazot, C.
    NEPHROLOGIE & THERAPEUTIQUE, 2010, 6 (03): : 151 - 157
  • [28] Using the newer Kidney Disease: Improving Global Outcomes criteria, beta-2-microglobulin levels associate with severity of acute kidney injury
    Barton, Kevin T.
    Kakajiwala, Aadil
    Dietzen, Dennis J.
    Goss, Charles W.
    Gu, Hongjie
    Dharnidharka, Vikas R.
    CLINICAL KIDNEY JOURNAL, 2018, 11 (06) : 797 - 802
  • [29] Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Introduction
    de Boer, Ian H.
    Rossing, Peter
    KIDNEY INTERNATIONAL, 2020, 98 (04) : S20 - +
  • [30] Improving outcomes in diabetes and chronic kidney disease: The basis for Canadian guidelines
    McFarlane, Philip A.
    Tobe, Sheldon W.
    Culleton, Bruce
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 (07) : 585 - 590